首页> 外文会议>International Forum on Progress on Post-Genome Technologies >Construction of the O45 ler Gene Deletion Mutant of the Enteropathogenic Escherichia coli
【24h】

Construction of the O45 ler Gene Deletion Mutant of the Enteropathogenic Escherichia coli

机译:肠致死大肠杆菌O45 LER基因缺失突变体的构建

获取原文

摘要

Enteropathogenic Escherichia coli (EPEC) are important pathogens in animals and human beings. In order to obtain an attenuated vaccine candidate, a ler deletion mutant of O45 strain was constructed and the cytotoxicity together with the safety of this candidate was also evaluated. EPEC O45 ler deletion mutant was constructed and the cytotoxicity assay showed that the mutant had no cytotoxicity to Vero cells in contrast with the virulent parent strain. After inoculation of the deletion mutant, the mice with O45 (Δler) gained weight normally and experienced no clinical signs. In contrast, the mice with O45 exhibited weight loss and all dead in four days. In conclusion, O45 (Δler) deletion mutant was successfully obtained and all the data from cytotoxicity and safety assays demonstrated that O45 (Δler) deletion mutant might be an attenuated vaccine candidate.
机译:肠寄生大肠杆菌(EPEC)是动物和人类的重要病原体。为了获得衰减的疫苗候选物,还建立了O45菌株的LER缺失突变体,并且还评估了细胞毒性以及该候选的安全性。构建了EPEC O45 LER缺失突变体,并且细胞毒性测定表明,与毒力母体菌株相比,突变体对VERO细胞没有细胞毒性。在接受缺失突变体之后,用O45(ΔLER)的小鼠正常获得重量,并且没有临床迹象。相比之下,o45的小鼠表现出体重减轻,四天内所有死亡。总之,成功获得O45(ΔL)缺失突变体,并且来自细胞毒性和安全测定的所有数据证明O45(ΔL)缺失突变体可能是衰减的疫苗候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号